5 nov 2019
CPhI Worldwide 2019
Apotex

Apotex

Exhibitor at CPhI Worldwide 2019 stand 80H100, Integrated Pharma

About us

For over 40 years, Apotex has been a trusted name in the Canadian pharmaceutical community, providing patients with increased access to quality, affordable medicines.  A global company, we operate distinct lines of business including Global Generics (with 300+ prescription and OTC drugs in over 4000 doses and formats), Apotex Pharmachem (with 200+ API’s developed for major markets), Apobiologix for biosimilars and complex molecule development, and ApoPharma for innovative medicines.   Apotex Inc. offers a wide out-licensing portfolio of over 100 finished drug products and 200 active pharmaceutical ingredients (API), backed by a robust development pipeline focused on the top global generic priorities.    Apotex Inc. is also interested in licensing pharmaceuticals from drug development/delivery companies who want to grow their business in the US, Canada, Caribbean, EMEA, APAC, and LATAM markets by utilizing our “Best in Class” commercial teams to sell, market and distribute their products.      Since our founding, we have been dedicated to maintaining sustainable, state-of-the-art processes – processes that ensure our products meet the highest quality and safety standards in all markets. Through our unwavering commitment to excellence and innovation, we help communities across the world live longer, healthier lives.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: APIs |Finished Dosage Forms |Biopharmaceuticals More

Products featured at CPhI Worldwide 2019

Categories affiliated with Apotex

Apotex

Event information

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 80H100